NEPH

Conviction 10HealthcareScan · Thu, Jun 25, 2026

NEPH$3.29-1.94%

ResistanceSupportVol 14

Vol MA14 10.71K

Mar 26Apr 14May 1May 19Jun 8Jun 25

NEPHROS INCSURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.nephros.com ↗

Price3.29

Change-1.94%

Gap+4.93%

Rel volume0.85×

Avg volume11.5K

Avg $ vol39.21K

SMA 203.39

SMA 503.30

SMA 2004.15

Price vs 50-0.33%

Price vs 200-20.87%

MA stackbearish

50/200 cross—

Supertrendup · 2.98

RSI (14)48

MACD hist-0.01

MACD cross—

Stoch %K / %D32 / 34

ADX (14)27

+DI / −DI20 / 10

RSI divergence—

MACD divergence—

ATR %+6.33%

ADR %5.30%

52w high5.79

52w low2.78

From 52w high-43.22%

Above 52w low+18.17%

New 52w highNo

SqueezeOff

Bollinger width24.02%

%B0.37

Donchian pos25.74%

Donchian high3.82

Donchian low3.10

AVWAP (52w high)4.10

vs AVWAP high-19.88%

AVWAP (52w low)3.27

vs AVWAP low+0.53%

OBV trendFlat

Chaikin MF (20)-0.14

Today vs 20d0.85×

Avg vol (14d)10.71K

Avg vol (20d)11.5K

Avg $ vol (20d)39.21K

Market cap35.66M

RS 3m (vs SPY)-2.42%

RS 6m (vs SPY)-41.14%

RS line new highNo

Trend template0/8

Technical rank23.6

1 week+2.66%

1 month-8.24%

3 months+8.77%

6 months-32.27%

1 year-21.03%

YTD-30.84%

P/E29.87

P/B4.27

P/S1.90

P/FCF22.43

EPS0.1100

Div yield—

ROE14.29%

ROA8.66%

Debt/Eq0.07

Current4.55

EV/EBITDA27.65

Gross margin61.87%

Net margin6.35%

Rev growth32.67%

EPS growth1513.51%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value32.22M

Revenue5.21M

Net income140K

Gross profit2.99M

Free cash flow1.59M

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ExchangeNasdaq

Shares out10.86M

Employees36

ListedTue, Sep 21, 2004

Free float5.46M

Float %51.4%

Short interest25.3K

Days to cover0.9d

Short volume45.2%

Squeeze score9 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction10 / 100

Pattern quality—

Tech rank23.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.79

Support3.00

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NEPH

All disclosures →

No recent disclosed trades by Congress in NEPH. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NEPH · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Amron Arthur H Director · Common Stock · 2026-05-11	Grant	3.57K	—	2026-05-11	2026-06-12

SEC filings

EDGAR filings in NEPH · 1 recent

EDGAR →

8-K8-KMon, Jun 15, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.